Pedgaonkar, G., Sridevi, J., Jeankumar, V., Saxena, S., Devi, P., Renuka, J., … Sriram, D. (2014). Development of 2-(4-oxoquinazolin-3(4H)-yl)acetamide derivatives as novel enoyl-acyl carrier protein reductase (InhA) inhibitors for the treatment of tuberculosis. European Journal of Medicinal Chemistry, 86, 613-27. https://doi.org/10.1016/j.ejmech.2014.09.028 (Original work published 2014)
P Yogeeswari
First name:
P
Last name:
Yogeeswari
Saxena, S., Renuka, J., Jeankumar, V., Yogeeswari, P., & Sriram, D. Mycobacterial DNA gyrB inhibitors: Ligand based pharmacophore modelling and in vitro enzyme inhibition studies. Current Topics in Medicinal Chemistry, 14(17), 1990-2005. Retrieved from http://www.eurekaselect.com/124977/article (Original work published 2014)
Pedgaonkar, G., Sridevi, J., Jeankumar, V., Saxena, S., Devi, P., Renuka, J., … Sriram, D. (2014). Development of benzo d oxazol-2(3H)-ones derivatives as novel inhibitors of Mycobacterium tuberculosis InhA. Bioorganic & Medicinal Chemistry, 22(21), 6134-45. https://doi.org/10.1016/j.bmc.2014.08.031 (Original work published 2014)
Samala, G., Devi, B., Saxena, S., Gunda, S., Yogeeswari, P., & Sriram, D. (2016). Anti-tubercular activities of 5,6,7,8-tetrahydrobenzo 4,5 thieno 2,3-d pyrimidin-4-amine analogues endowed with high activity toward non-replicative Mycobacterium tuberculosis. Bioorganic & Medicinal Chemistry, 24(21), 5556-5564. https://doi.org/10.1016/j.bmc.2016.09.012 (Original work published 2016)
Jeankumar, V., Reshma, R., Janupally, R., Saxena, S., Sridevi, J., Medapi, B., … Sriram, D. (2015). Enabling the (3 + 2) cycloaddition reaction in assembling newer anti-tubercular lead acting through the inhibition of the gyrase ATPase domain: lead optimization and structure activity profiling. Organic & Biomolecular Chemistry, 13(8), 2423-31. https://doi.org/10.1039/c4ob02049a (Original work published 2015)
Saxena, S., Samala, G., Sridevi, J., Devi, P., Yogeeswari, P., & Sriram, D. (2015). Design and development of novel Mycobacterium tuberculosis L-alanine dehydrogenase inhibitors. European Journal of Medicinal Chemistry, 92, 401-14. https://doi.org/10.1016/j.ejmech.2014.12.046 (Original work published 2015)
Devi, P., Jogula, S., Reddy, A., Saxena, S., Sridevi, J., Sriram, D., & Yogeeswari, P. (2015). Design of Novel Mycobacterium tuberculosis Pantothenate Synthetase Inhibitors: Virtual Screening, Synthesis and In Vitro Biological Activities. Molecular Informatics, 34(2-3), 147-59. https://doi.org/10.1002/minf.201400120
Saxena, S., Samala, G., Renuka, J., Sridevi, J., Yogeeswari, P., & Sriram, D. (2015). Development of 2-amino-5-phenylthiophene-3-carboxamide derivatives as novel inhibitors of Mycobacterium tuberculosis DNA GyrB domain. Bioorganic & Medicinal Chemistry, 23(7), 1402-12. https://doi.org/10.1016/j.bmc.2015.02.032 (Original work published 2015)
Medapi, B., Renuka, J., Saxena, S., Sridevi, J., Medishetti, R., Kulkarni, P., … Sriram, D. (2015). Design and synthesis of novel quinoline-aminopiperidine hybrid analogues as Mycobacterium tuberculosis DNA gyraseB inhibitors. Bioorganic & Medicinal Chemistry, 23(9), 2062-78. https://doi.org/10.1016/j.bmc.2015.03.004 (Original work published 2015)
Petersen, G., Saxena, S., Renuka, J., , Yogeeswari, P., Santos, D., … Sriram, D. (2015). Structure-based virtual screening as a tool for the identification of novel inhibitors against Mycobacterium tuberculosis 3-dehydroquinate dehydratase. Journal of Molecular Graphics & Modelling, 60, 124-31. https://doi.org/10.1016/j.jmgm.2015.05.001